Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Neostem, Inc.

Caladrius Biosciences (NASDAQ: NBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc. It is headquartered in New York, New York.

Investment goal date:
Dividends reinvested
Neostem, Inc. NBS report Q1 2015
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2015
2015-11-09
--
--
Q2 2015
2015-08-06
--
--
Q1 2015
2015-05-05
0.0000
-0.5300
Q4 2014
2015-03-02
-0.3200
-0.3200
Q3 2014
2014-10-30
-0.4800
-0.4800
Q2 2014
2014-08-07
-0.4000
-0.4000
Q1 2014
2014-05-08
-0.4900
-0.4900
Q4 2013
2014-03-13
-0.4700
-0.4700
Q3 2013
2013-11-07
-0.4500
-0.4500
Q2 2013
2013-08-08
-0.4600
-0.5000
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
MYERS STEVEN S
0.1000% (36159)
NBS /
BERMAN RICHARD J
0.0200% (7177)
ADXS / APRI / NBS /
VACZY CATHERINE M
0.2000% (71234)
NBS /
KLOSK STEVEN M
0.0300% (9065)
CBM / NBS /
VATERS ROBERT S
0.6500% (228750)
NBS /
GREENACRE MARTYN D
0.2500% (88531)
CRIS / NBS /
TRABER PETER G
0.0200% (6865)
GALT / NBS /
Mazzo David J
0.1600% (56551)
AVNR / NBS / PSDV / RGDO /
Smith Robin L
0.9900% (347285)
NBS / RMTI / SGNL /
Wei Eric
0.4900% (172223)
NBS /
RimAsia Capital Partners, L.P.
6.2700% (2210988)
NBS /
BROWN GREGORY B
0.0200% (6715)
NBS /
BERNSTEIN DREW
0.0300% (10000)
NBS /
Dickey Robert IV
0.0300% (12066)
HEB / NBS /
Pecora Andrew L
1.1200% (393784)
CGIX / NBS / TLOG /
Preti Robert A
0.1000% (33786)
NBS /
Potter Stephen W
0.0400% (14016)
AGTC / NBS / OSIR /
Talamo Joseph
0.0400% (15619)
NBS /
RimAsia Capital Partners Manager, Ltd.
6.3100% (2222988)
NBS /
% ()